Ann: Pfizer raises scheme consideration to A$0.208 per share, page-37

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 37 Last

Share
Profile

Follow
Thebeanstalk

16 Posts.

3

06/08/22

13:02

Post #: 62961795
Share

Originally posted by TheSanDiegoKid: ↑

The covid detection market will be worth +$100B!!!
Not sure how many of you remember the conference call back in March after the company first announced positive results of the covid detection app.

That call featured Professor Catherine Bennett, Chair of Epidemiology at Deakin University. She went on to state how not only "The simplicity, ease of use and unlimited scalability of ResApp’s test will be welcomed by public health officials around the world.” - But that the global covid diagnostic market is predicted to reach in excess of $100B USD annually by 2027 (less than five years away).

And some people are happy to sell the most disruptive tech and data set in this space for approx 1/1000th of that annual revenue... WHY?!!!!Let's not lose focus on what is happening here. One of the world's most powerful and wealthy companies wants to essentially steal this tech to reap the rewards themselves, and they have tried their best to package it as a good deal for the share holders in order to convince them this is our best option.

Imagine what this could be worth when we stick to the No vote and accept only a partnership deal with them or another appropriate candidate!!!

I'd imagine a decent chunk of that $100B would be having a bit of an impact on the future share price.

Even if we captured 1/1000th of that potential market, we'd be making a year what they are trying to convince us the entire business is worth!

And then ofc there is Dx and Sleepcheck to add to the mix.

Let's go shareholders! Vote No!!!!!!

Expand

Good for you kidd your on the money common Rappers Remember When The going Gets Tough Rappers keep Going say no!! Lets not falter now and roll over to be Rheemd stay STRONG

RAP Price at posting: 19.0¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BUX

Buxton projects new graphite province discovery at WA Narryer play

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 65 more messages in this thread...

First 37 Last

Add RAP (ASX) to my watchlist

Ann: Pfizer raises scheme consideration to A$0.208 per share, page-37

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News